PMI: Illicit Trade in Smoke-Free Products in the Philippines Could Reach 80%; Major Gap Between China’s Exports and PH Imports

Sep.22.2025
PMI: Illicit Trade in Smoke-Free Products in the Philippines Could Reach 80%; Major Gap Between China’s Exports and PH Imports
At the Financial Times Illicit Trade Forum in Taguig City, Rodney Van Dooren, Regional Illicit Trade Expert at Philip Morris International (PMI), said illicit consumption of smoke-free products (including e-cigarettes) in the Philippines “could be as high as 80%.” He cited a large discrepancy between China’s e-cigarette export figures and the Philippines’ official import data, suggesting significant volumes are entering outside formal channels.

Key Points

 

  • Scale estimate: Illicit consumption of smoke-free products may reach 80% (company expert assessment).

 

  • Trade gap: A “large mismatch” between China’s exports and Philippine imports points to substantial undeclared inflows.

 

  • Public-health risks: Counterfeit cigarettes were cited with tar levels +160% and carbon monoxide +130%, with detections of cadmium and lead; substandard factories reportedly found foreign contaminants.

 

  • Pandemic effect: Illicit cigarette share reportedly rose from 6% to 20% in the Philippines; from 5% to 28% in Thailand (as stated at the forum).

 

  • Business impact: Illicit trade diverts volume from compliant firms, while look-alike packaging complicates consumer risk recognition.

 

  • Policy & cooperation: While DTI and BIR have stepped up enforcement, the issue was described as an “upstream policy” problem requiring cooperation among China, India, and ASEAN.

 

  • Regional opportunity: With the Philippines set to chair ASEAN next year, the country is seen as well placed to lead regional anti-illicit trade efforts.

 

2Firsts, September 22, 2025 — From Manilatimes's Report, Speaking at the Financial Times Illicit Trade Forum in Taguig, Metro Manila, PMI regional illicit trade expert Rodney Van Dooren said illicit consumption of smoke-free products—including e-vapor products—in the Philippines could reach as high as 80%. He pointed to a “large discrepancy” between China’s export statistics for e-cigarettes and the Philippines’ official import records, indicating that a substantial share of products may be entering the market outside formal channels.

 

Van Dooren also highlighted public-health concerns. While “there is no such thing as a safe cigarette,” he argued that counterfeit cigarettes can be even more harmful, citing figures that tar levels could be 160% higher and carbon monoxide 130% higher, with detections of heavy metals such as cadmium and lead. He added that products from substandard factories have reportedly contained foreign matter such as feces and insects. During the pandemic, online channels accelerated illicit consumption: the share of illicit cigarettes was said to have risen from about 6% to 20% in the Philippines, and from 5% to 28% in Thailand.

 

On policy and enforcement, he acknowledged stepped-up efforts by the Department of Trade and Industry (DTI) and the Bureau of Internal Revenue (BIR) under new laws. However, he framed the challenge as an “upstream policy” issue requiring cross-border coordination, noting the gray area where a product may be legal in the place of manufacture but lacks a legitimate market in the destination country. He urged greater cooperation among China, India, and ASEAN member states. With the Philippines slated to chair ASEAN next year, Van Dooren said the country is in a strong position to spearhead regional action against illicit trade.

 

Industry observers argue that, to reduce public-health risks while preserving a compliant market, next steps should include tighter source-country oversight, cross-border data sharing, coordinated customs actions, stronger online-platform enforcement, and clear market-access rules.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Product | BAT Expands VELO Travellers’ Collection With Mexico, Spain and Sweden Summer Edition Nicotine Pouches
Product | BAT Expands VELO Travellers’ Collection With Mexico, Spain and Sweden Summer Edition Nicotine Pouches
British American Tobacco (BAT) Global Travel Retail has expanded the VELO Travellers’ Collection with three new Summer Editions: Mexico, Spain and Sweden. Inspired by destination themes, the new nicotine pouch variants are designed for global travel-retail channels. The launch further strengthens VELO’s positioning as a travel-retail exclusive product collection.
Aug.27